DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Clot Management Devices Market (2016-2022)" report to their offering.
Blood clotting, also known as coagulation, is the body's response to an injury to prevent bleeding. It prevents excessive bleeding when the blood vessels are injured. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot formation in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely.
Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT. As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reasons for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure.
Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, Neurovascular Embolectomy Devices and Inferior Vena Cava Filters. Based on End User type, the market is segmented into Hospitals and Diagnostic Centres.
- Teleflex Inc.
- Edwards Lifesciences Corporation
- Medtronic Plc
- Boston Scientific Corporation
- LeMaitre Vascular Inc.
- Straub Medical AG
- Cook Medical Inc.
- Johnson & Johnson
Key Topics Covered:
1. Market Scope & Methodology
2. Executive Summary
3. Market Overview
4. Global Clot Management Market by Product
5. Global Clot Management Market by End User
6. Global Clot Management Market by Region
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/sc8r4f/global_clot.